NCX 2057, a novel NO‐releasing derivative of ferulic acid, suppresses inflammatory and nociceptive responses in <i>in vitro</i> and <i>in vivo</i> models
Daniela Ronchetti(Tethys Research Institute), Francesco Impagnatiello(Tethys Research Institute)
Cited by 38
Related Papers
Characterization of the Potent and Highly Selective A2A Receptor Antagonists Preladenant and SCH 412348 [7-[2-[4-2,4-Difluorophenyl]-1-piperazinyl]ethyl]-2-(2-furanyl)-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine] in Rodent Models of Movement Disorders and Depression
|Journal of Pharmacology and Experimental Therapeutics|2009|149